0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Warfarin Therapy for Atrial Fibrillation: The Patient's Preference Is Important

Tom Fahey, MD; Alan A. Montgomery, PhD; Tim J. Peters, PhD
Arch Intern Med. 2000;160(15):2393. doi:.
Text Size: A A A
Published online

Extract

Tammy Bungard and colleagues1 correctly identify patient-, physician-, and health care system–related barriers to warfarin use in patients with atrial fibrillation. However, they do not identify patients' preferences as an important element in decision making for treatment of this condition.

Protheroe et al2 have recently completed a study examining patients' preferences for warfarin in an elderly population (aged 70 to 85 years) with atrial fibrillation. Patients with atrial fibrillation (N = 260) were selected from 8 general practices in Bristol, England; 97 of these patients (50% of those eligible) had no contraindications to warfarin, no other concomitant medical problems, and were able to express their preferences as measured by the time trade-off method. Just under half (n = 48; 49%) were already taking warfarin. When their individual probability of suffering a stroke was combined with their utility scores by means of decision analysis, 59 (61%) would accept warfarin therapy for their atrial fibrillation. This contrasts with the proportion deemed to benefit from treatment if treatment was offered solely on the basis of absolute risk (n = 70, 72%) and consensus conference guidelines (n = 89; 95%).3,4 Furthermore, the chance-corrected measure of agreement (κ statistic) for treatment preferences based on individualized decision analysis compared with absolute risk and consensus recommendations was 0.25 and 0.09, respectively, indicating "poor" agreement. Of those patients already taking warfarin, 17 (35%) would not take warfarin if their preferences were taken into account by means of decision analysis, while 28 patients (57%) who were not taking warfarin would accept treatment according to their decision analysis.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 13

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario

brightcove.createExperiences();